8-K
filed May 4, 2026, 7:59 PM ET
ticker ERNA
CIK 0000748592
other material
confidence high
sentiment neutral
materiality 0.60
Ernexa Therapeutics effects 1-for-25 reverse stock split, effective May 4, 2026
Ernexa Therapeutics Inc.
- Reverse stock split at 1-for-25 ratio; trading on split-adjusted basis began at market open on May 4, 2026.
- Certificate of Amendment filed with Delaware Secretary of State on May 1, 2026.
- New CUSIP number for common stock post-split: 114082407.
- Common stock (ERNA) and warrants (ERNAW) trade on Nasdaq under split-adjusted terms.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-021112
- form_type
- 8-K
- ticker
- ERNA
- cik
- 0000748592
- company_name
- Ernexa Therapeutics Inc.
- filed_at
- 2026-05-04T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.700265+00:00
- generated_at
- 2026-05-15T00:09:20.695089+00:00
- sec_items
- ["5.03", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-021112
- json_url
- https://secwatch.observer/filing/0001493152-26-021112.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-021112.md
- text_url
- https://secwatch.observer/filing/0001493152-26-021112.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/748592/000149315226021112/0001493152-26-021112-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/748592/000149315226021112/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IOT
Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026
Samsara Inc.
June 1, 2026, 4:07 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.
Filing page
SEC filing
GIG
GigCapital7 domestication from Cayman Islands to Delaware effective May 8 after shareholder vote
GigCapital7 Corp.
May 11, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 8, 2026, GigCapital7 effectuated the Domestication by filing (i) a voluntary declaration pursuant to Section 206(3) of the Companies Act (revised) of the Acts of the Cayman Islands, (ii) a certificate of corporate domestication with the Secretary of State of the State of Delaware (the “ DE SoS ”), and (iii) an interim certificate of incorporation with the DE SoS (the “ Domesticated GigCapital7 Charter ”). Domesticated GigCapital7 also adopted bylaws (the “ Domesticated GigCapital7 Bylaws ” and together with the Domesticated GigCapital7 Charter, the “ Domesticated GigCapital7 Governing Documents ”) in connection with the Domestication.
Filing page
SEC filing
OXSQ
Oxford Square Capital increases authorized shares from 100M to 300M via Articles of Amendment
Oxford Square Capital Corp.
May 11, 2026, 7:59 PM ET
other_material
Items 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 8, 2026, Oxford Square Capital Corp., a Maryland corporation (the “Company”), filed an Articles of Amendment (the “Articles of Amendment”) to its charter with the State Department of Assessments and Taxation of Maryland (“SDAT”) to increase the total number of authorized shares of capital stock of the Company from 100,000,000 shares to 300,000,000 shares, initially consisting of 300,000,000 shares of common stock, par value $0.01 per share.
Filing page
SEC filing
SAGU
Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE
Shreya Acquisition Group
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
Filing page
SEC filing
AEIS
AEIS stockholders approve doubling of authorized shares to 140M and expansion of equity plan to 4.9M shares
ADVANCED ENERGY INDUSTRIES INC
May 8, 2026, 7:59 PM ET
other_material
Items 5.02, 5.07, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
the amendment increases the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares. The amendment became effective upon the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 7, 2026.
Filing page
SEC filing
PSEC
Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares
PROSPECT CAPITAL CORP
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
Comparable filing
On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.